What this means
This is a planned trial that has not started enrolling people yet. It will look at whether a supplement changes how muscles respond to exercise.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 20–90 · Women over 60 (no number stated)
- Where
- Not listed
The science
- Registered title
- Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60
- Trial ID
- NCT07703774 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Myeloid Cell Infiltration
- What is tested
- Resistance exercise
- Sponsor
- University of Taipei
- Ages
- 20 Years to 90 Years
- Dates
- First posted Jul 14, 2026 · updated Jul 22, 2026
Registry summary
This study will provide novel insights into the role of bone marrow-derived stem cells in muscle adaptation to long-term exercise and advance our understanding of an Rg-1 based supplement-Senactiv® as a potential intervention for preventing sarcopenia and cognitive decline in older adults.